Chlamydia/Gonorrhea specimen source distribution by year (CT/GC test data)
| 2007 | 2008† | 2009 | 2010 | % change, | |||||
| N | % | N | % | N | % | N | % | 2007–2010 | |
| Clinican– Obtained* | 25 076 | 52.0% | 23 231 | 45.3% | 22 814 | 42.2% | 8885 | 39.8% | −12.2% |
| Urine | 23 024 | 47.7% | 26 785 | 52.2% | 25 257 | 46.7% | 9677 | 43.4% | −4.4% |
| SOV | 123 | 0.3% | 1290 | 2.5% | 5984 | 11.1% | 3743 | 16.8% | 16.6% |
| Total | 48 223 | 100.0% | 51 306 | 100.0% | 54 055 | 100.0% | 22 305 | 100.0% | 0.0% |
* Clinician–obtained method include endocervical and clinician –obtained vaginal swabs.
† SOV promotion intervention initiated in 2008.
χ2<0.001.